EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retinoic acid‐loaded liposomes induce human mucosal CD103 + dendritic cells that inhibit Th17 cells and drive regulatory T‐cell development in vitro

Noémi Anna Nagy iD, Florianne M J Hafkamp, Rinske Sparrius, Rico Bas, Fernando Lozano Vigario, Toni M M van Capel, Ronald van Ree, Teunis B H Geijtenbeek iD, Bram Slütter, Sander W Tas, Esther C de Jong

European Journal of Immunology · 2024-05 · 54 (5)

DOI: 10.1002/eji.202350839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 02.03.2024. Verfasst von Noémi Anna Nagy und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, A…. Hauptthemen laut MEDLINE: Tretinoin, Integrin alpha Chains, Th17 Cells, Dendritic Cells. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Holland- SGF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The active vitamin A metabolite, all‐trans‐retinoic acid (RA), primes precursor dendritic cells (DCs) into a mucosal phenotype with tolerogenic properties characterized by the expression of integrin CD103. CD103 + DCs can counteract pathogenic Th1 and Th17 in inflammatory bowel disease (IBD) or celiac disease (CD). Tolerogenic manipulation of DCs using nanoparticles carrying tolerogenic adjuvants and disease‐specific antigens is a valuable treatment strategy to induce antigen‐specific mucosal tolerance in vivo. Here, we investigated the effects of RA‐loaded liposomes on human DC phenotype and function, including DC‐driven T‐cell development, both during the generation of monocyte‐derived DCs (moDCs) as well as by priming immature moDCs. RA liposomes drove CD103 + DC differentiation as well as ALDH1A2 expression in DCs. Neutrophil‐dependent Th17 cell development was reduced by RA‐liposome‐differentiated and RA‐liposome‐primed DCs. Moreover, RA liposome treatment shifted T‐cell development toward a Th2 cell profile. Importantly, RA liposomes induced the development of IL‐10‐producing and FoxP3 + regulatory T cells (Tregs) of various Treg subsets, including ICOS + Tregs, that were potent inhibitors of bystander memory T‐cell proliferation. Taken together, RA‐loaded liposomes could be a novel treatment avenue for IBD or CD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TretinoinIntegrin alpha ChainsTh17 CellsDendritic CellsAntigens, CDT-Lymphocytes, RegulatoryLiposomesCell DifferentiationRetinal DehydrogenaseAldehyde Dehydrogenase 1 FamilyHumansImmune ToleranceCells, CulturedInterleukin-10Forkhead Transcription FactorsInflammatory Bowel DiseasesLymphocyte ActivationCeliac Disease

Stichwörter der Autor:innen

Dendritic cells(s)Immune regulationImmunotherapyMucosal immunityRegulatory T cell(s)

Substanzen

TretinoinIntegrin alpha Chainsalpha E integrinsAntigens, CDLiposomesRetinal DehydrogenaseAldehyde Dehydrogenase 1 FamilyALDH1A2 protein, humanInterleukin-10Forkhead Transcription Factors

Autor:innen und Institutionen

  • Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Infection & Immunity, University of Amsterdam, Amsterdam, The Netherlands.
  • Division of BioTherapeutics, Leiden Academic Center for Drug Research, Leiden, The Netherlands.
  • Department of Otorhinolaryngology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Department of Rheumatology and Clinical Immunology, Amsterdam University Medical Centers, Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.

ORCID-Profile: Noémi Anna Nagy, Teunis B H Geijtenbeek

Förderung

  • Health Holland- SGF

Zitieren

APA

Nagy, N. A., Hafkamp, F. M. J., Sparrius, R., Bas, R., Lozano Vigario, F., van Capel, T. M. M., van Ree, R., Geijtenbeek, T. B. H., Slütter, B., Tas, S. W., & de Jong, E. C. (2024). Retinoic acid‐loaded liposomes induce human mucosal CD103 + dendritic cells that inhibit Th17 cells and drive regulatory T‐cell development in vitro. European Journal of Immunology, 54(5). https://doi.org/10.1002/eji.202350839

Vancouver

Nagy NA, Hafkamp FMJ, Sparrius R, Bas R, Lozano Vigario F, van Capel TMM, et al. Retinoic acid‐loaded liposomes induce human mucosal CD103 + dendritic cells that inhibit Th17 cells and drive regulatory T‐cell development in vitro. European Journal of Immunology. 2024;54(5). doi:10.1002/eji.202350839

BibTeX
@article{Nagy2024,
  author = {Nagy, Noémi Anna and Hafkamp, Florianne M J and Sparrius, Rinske and Bas, Rico and Lozano Vigario, Fernando and van Capel, Toni M M and van Ree, Ronald and Geijtenbeek, Teunis B H and Slütter, Bram and Tas, Sander W and de Jong, Esther C},
  title = {Retinoic acid‐loaded liposomes induce human mucosal CD103 + dendritic cells that inhibit Th17 cells and drive regulatory T‐cell development in vitro},
  journal = {European Journal of Immunology},
  year = {2024},
  volume = {54},
  number = {5},
  doi = {10.1002/eji.202350839}
}
Kostenlos starten →